Loccus, a biotechnology startup, was founded in 2002 in Brazil. The company specializes in providing custom automation solutions for molecular biology laboratories, including equipment, reagents, and services. With a strong focus on innovation and product quality, Loccus caters to the clinical, research, and agribusiness markets. The company's dedication to accelerating national scientific development is evident in its 100% Brazilian ownership and commitment to personalized customer service. Despite lacking specific details on its headquarters, last investment, or investors, Loccus presents an enticing opportunity for venture capitalists seeking to invest in the rapidly evolving biotechnology and manufacturing industries. With its proven track record and dedication to scientific advancement, Loccus stands out as a promising investment in the field of molecular biology.
There is no investment information
No recent news or press coverage available for Loccus.